Seqens announces China investment
Seqens is to make an investment of nearly RMB 300 million (€40 million) in three major new production capacity projects for the healthcare and cosmetics markets at Taixing and Wuxi, China. CEO Pierre Luzeau (pictured) announced this during a meeting President Macron had with between President Xi Jinping and Macron in Beijing on 6 April.
“These three projects will complement Seqens' industrial facilities and investments in Europe with sustainable and competitive production closer to local markets and will support the growing demand of the healthcare and cosmetics markets for safe and sustainable products,” the company stated. No further details have yet been disclosed.